The role of GPR84 signaling during skin repair
The role of GPR84 signaling during skin repair
批准号:
10637039
负责人:
BRETT SHOOK
金额:
$46.57万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2028-02-29
关键词:
AcuteAdipocytesAgingAgonistBiologyBone MarrowCell CountCell physiologyCellsCellular biologyChronicCommunicationComplexDataDermalDevelopmentDiabetes MellitusDiseaseEpithelial CellsEpitheliumFoundationsG-Protein-Coupled ReceptorsGPR84 geneGene ExpressionGene Expression ProfileGeneticGenetic ModelsGenomicsGoalsGrowth FactorImpaired healingImpaired wound healingIn VitroInflammationInflammatoryInflammatory ResponseInjuryKnockout MiceLearningLinkLipidsLipolysisLoxP-flanked alleleMacrophageMedium chain fatty acidMolecularMusMyelogenousMyeloid CellsPathologicPatientsPhasePopulations at RiskProcessProliferatingQualifyingRegulationRoleSignal PathwaySignal TransductionSkinSkin repairSkin wound healingSolidStromal CellsSystemTestingTherapeuticTherapeutic UsesTissuesWorkacute woundagedantagonistcell typecytokinediabeticexperimental studygenomic toolshealingimmune cell infiltratein vitro Assayin vivoinsightkeratinocytemigrationmouse modelnon-healing woundsnovelpharmacologicpredictive toolsreceptorrecruitrepairedreparative processresponse to injurysingle-cell RNA sequencingsmall moleculestem cellstargeted treatmenttissue repairtoolwoundwound bedwound healingwound treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Efficient wound healing requires complex cellular communication between tissue-resident
non-immune cells and infiltrating immune cells. While much has been learned about how
cytokines and growth factors contribute to acute wound healing, we know very little about how
lipid signaling regulates acute inflammation and tissue repair, and identification of new
mechanisms that govern acute inflammation and repair is needed. We previously demonstrated
that inhibiting dermal adipocyte lipolysis led to reduced macrophage numbers during early
inflammation and delayed repair, yet the mechanism(s) linking adipocyte lipolysis to efficient
inflammation and repair have not been identified. Given the rising numbers of diabetic and aged
patients, it is imperative to define molecular underpinnings that promote a healthy acute
inflammatory response and to identify druggable mechanisms to treat inflammation and non-
healing wounds.
Inhibition of injury-induced dermal adipocyte lipolysis significantly reduces the abundance
of medium-chain fatty acids (MCFAs). Recently, GPR84 was identified to be an MCFA receptor
that is expressed by bone marrow-derived myeloid cells and during tissue inflammation. Activation
of GPR84 in vitro increases macrophage migration and enhances pro-inflammatory gene
expression; however, its role in skin and the in vivo mechanism of action is not well defined. We
observe increased GPR84-expression during wound-induced inflammation and found that
administration of a GPR84 agonist increases macrophage numbers. Additionally, systemic
administration of a GPR84 antagonist decreases wound bed macrophages and delays tissue
repair. Based on our preliminary data, we hypothesize that GPR84 signaling is required to support
macrophage numbers and subsequent repair during injury-induced inflammation. We will
combine our team’s tools and expertise in adipocyte, keratinocyte, and macrophage biology with
single-cell data interrogation to validate this hypothesis with the following Specific Aims: (1) Use
mouse models to determine how GPR84 signaling controls macrophage numbers and
subsequent tissue repair after injury, and (2) define how MCFA/GPR84 signaling directly
regulates myeloid cell function during skin wound healing and (3) define how epithelial GPR84
signaling contributes to keratinocyte function after injury.
GPR84 signaling represents a new window to better understand mechanisms that regulate
the injury response. Findings from this proposed work could lay a solid foundation for developing
new tools that predict and enhance therapeutic treatment of wound healing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: